THIS ANNOUNCEMENT RELATES TO THE DISCLOSURE OF INFORMATION THAT QUALIFIED AS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE MARKET ABUSE REGULATION (EU) 596/2014.
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO OR TO ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES, ITS TERRITORIES AND POSSESSIONS, ANY STATE OF THE UNITED STATES OR THE DISTRICT OF COLUMBIA (THE “UNITED STATES”) OR IN OR INTO ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO RELEASE, PUBLISH OR DISTRIBUTE THIS DOCUMENT.
In reference to the current report no. 27/2025 dated 1 October 2025, the Management Board of Globe Trade Centre S.A. (the “Company”) announces that on 3 October 2025, GTC Finance DAC (the “SPV”) has successfully priced an offering comprising senior secured notes with a total nominal value of EUR 455 million, bearing interest at 6.50% per annum and with a maturity date of October 2030 (the “New Notes”).
The SPV, being a special purpose company established for the purpose of issuing the New Notes and neither a subsidiary of GTC Aurora Luxembourg S.A. (“GTC Aurora”) nor the Company, has successfully priced the New Notes. The successful pricing of the New Notes constitutes a material advancement towards fulfilling the condition prerequisite to the tender offer announced by GTC Real Estate Development Hungary Zrt. for the outstanding EUR 494 million notes (due in 2026), with a coupon of 2.25%, issued by GTC Aurora (the “Notes”; the “Offer”).
The gross proceeds of the New Notes, net of certain fees and expenses, will be deposited in an escrow account and pledged in favour of the security agent acting in its own name and for the benefit of the trustee, agents and holders of the New Notes pursuant to an escrow charge. Upon completion of the Offer, such proceeds will be used to fund the settlement of the Offer and, in due course, for the full repayment of any remaining Notes.
The settlement of the New Notes is expected to take place on 10 October 2025, and the New Notes will be listed on the Global Exchange Market of Euronext Dublin.
Legal basis: Article 17 (1) of Regulation (EU) No 596/2014 of the European Parliament and of the Council on market abuse (market abuse regulation) and repealing Directive 2003/6/EC of the European Parliament and of the Council and Commission Directives 2003/124/EC, 2003/125/EC and 2004/72/EC (confidential information).
Signed:
/s/ Małgorzata Czaplicka
President of the Management Board
s/ Jacek Bagiński
Management Board Member